CAFs have been reported to promote angiogenesis via VEGF secretion in hepatocellular carcinoma, which is associated with up-regulation of enhancer of zeste homolog 2 (EZH2) and further inhibition of vasohibin 1 (VASH1) [19]. The gene discussed is VASH1; the disease is hepatocellular carcinoma.